ArticleDigestive diseases and sciences2026
Identification of Inflammation-Related Diagnostic Biomarker and Molecular Subtypes in Ulcerative Colitis Based on Machine Learning.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mechanisms and therapeutic prospects of DNA methylation-mucosal innate immunity crosstalk in inflammatory bowel disease.Frontiers in immunology · 2026Review
- A multi-machine learning framework identifies novel PANoptosis-related biomarkers and their immune landscape in ulcerative colitis: Insights from transcriptomics and experimental validation.Frontiers in immunology · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundUlcerative colitis (UC) is a chronic and recurrent form of inflammatory bowel disease, primarily involving sustained inflammation of the colonic mucosa. The inflammatory process plays a pivotal role in the pathogenesis and progression of the disorder. Therefore, we conducted this research to explore potential biomarkers and classify molecular subtypes with clinical relevance, which enhances diagnostic accuracy and informs personalized therapeutic strategies.
methodsTranscriptomic information was retrieved via the Gene Expression Omnibus (GEO) database. After merging the raw data, differential gene expression analysis was carried out, accompanied by a suite of bioinformatics tools. Gene Ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed. To screen feature genes, we employed both least absolute shrinkage and selection operator (LASSO) regression and random forest (RF), representing distinct approaches within machine learning. The effectiveness of the selected genes in distinguishing disease status was measured using receiver operating characteristic (ROC) curve analysis, and a nomogram was constructed. We employed single-sample gene set enrichment analysis (ssGSEA) to quantify the enrichment of immune-related signatures at the sample level, while gene set enrichment analysis (GSEA) was conducted to explore key signaling pathways. In addition, drug sensitivity analysis was performed to predict potential therapeutic responses. Ultimately, qRT-PCR analysis was performed to validate the expression patterns of the selected marker genes.
resultsTwo feature genes (CCL11 and MMP1) were identified as diagnostic biomarkers, both demonstrating strong diagnostic performance in ROC curve. A comprehensive nomogram was constructed and shown to possess considerable clinical utility. In addition, significant alterations in immune cell infiltration were identified, and key biological pathways were revealed through GSEA.
conclusionThis study identified CCL11 and MMP1 as inflammation-related diagnostic biomarkers for UC through integrated machine learning approaches, offering potential directions aiming at personalized diagnosis and therapeutic intervention.
Indexed as
Identifiers
40855234What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.